Table 4.
IR% values of 1–6 on human cancer cell lines at the 100 μg/mL. a
| Compound | K562 | HL-60 | HeLa | BGC-823 |
|---|---|---|---|---|
| 1 | 64.0% | 71.6% | 35.7% | 36.8% |
| 2 | 73.1% | 77.4% | 44.6% | 41.4% |
| 3 | 74.0% | 80.0% | 45.7% | 46.8% |
| 4 | 20.4% | 26.0% | 11.9% | — |
| 5 | 36.1% | 62.4% | 13.9% | 11.4% |
| 6 | 38.8% | 46.3% | 29.1% | 27.8% |
| Decotaxol | 49.2% | 46.9% | 41.7% | 44.1% |
a The cells were treated with the samples at 37 ºC for 24 h and then the IR% was measured by the MTT method; K562: Human chronic myelogenous leukemia K562 cell line, HL-60: Human acute promyelocytic leukemia HL-60 cell line, HeLa: Human cervical cancer HeLa cell line, BGC-823: Human gastric adenocarcinoma BGC-823 cell line; Decotaxol was used as positive control.